265 related articles for article (PubMed ID: 23728859)
1. Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas.
Sohn SY; Kim HJ; Jang HW; Kim SW; Chung JH
Head Neck; 2014 Jan; 36(1):43-6. PubMed ID: 23728859
[TBL] [Abstract][Full Text] [Related]
2. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role.
Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Berti P; Grasso L; Elisei R; Pinchera A; Vitti P
Endocr Relat Cancer; 2009 Dec; 16(4):1251-60. PubMed ID: 19528244
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological correlation of serum TSH in patients with thyroid nodule.
Mondal HP; Sen S; Sasmal S; Ghosal PK; Mukhopadhyay SK; Mukhopadhyay M
J Indian Med Assoc; 2011 May; 109(5):330, 335, 338. PubMed ID: 22187768
[TBL] [Abstract][Full Text] [Related]
4. Thyrotropin serum concentrations in patients with papillary thyroid microcancers.
Gerschpacher M; Göbl C; Anderwald C; Gessl A; Krebs M
Thyroid; 2010 Apr; 20(4):389-92. PubMed ID: 20210672
[TBL] [Abstract][Full Text] [Related]
5. Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease.
Rago T; Fiore E; Scutari M; Santini F; Di Coscio G; Romani R; Piaggi P; Ugolini C; Basolo F; Miccoli P; Pinchera A; Vitti P
Eur J Endocrinol; 2010 Apr; 162(4):763-70. PubMed ID: 20083557
[TBL] [Abstract][Full Text] [Related]
6. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.
Boelaert K; Horacek J; Holder RL; Watkinson JC; Sheppard MC; Franklyn JA
J Clin Endocrinol Metab; 2006 Nov; 91(11):4295-301. PubMed ID: 16868053
[TBL] [Abstract][Full Text] [Related]
7. Serum thyrotropin concentration in children with isolated thyroid nodules.
Mussa A; Salerno MC; Bona G; Wasniewska M; Segni M; Cassio A; Vigone MC; Gastaldi R; Iughetti L; Santanera A; Capalbo D; Matarazzo P; De Luca F; Weber G; Corrias A
J Pediatr; 2013 Nov; 163(5):1465-70. PubMed ID: 23972643
[TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS).
Kuru B; Atmaca A; Tarim IA; Kefeli M; Topgul K; Yoruker S; Elmali M; Danaci M
Eur J Surg Oncol; 2016 Jan; 42(1):87-93. PubMed ID: 26527545
[TBL] [Abstract][Full Text] [Related]
9. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
[TBL] [Abstract][Full Text] [Related]
10. Predictors of malignancy in patients with cytologically suspicious thyroid nodules.
Castro MR; Espiritu RP; Bahn RS; Henry MR; Gharib H; Caraballo PJ; Morris JC
Thyroid; 2011 Nov; 21(11):1191-8. PubMed ID: 22007937
[TBL] [Abstract][Full Text] [Related]
11. Thyroglobulin antibodies as a potential predictive marker of papillary thyroid carcinoma in patients with indeterminate cytology.
Karatzas T; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Boutzios G
Am J Surg; 2016 Nov; 212(5):946-952. PubMed ID: 27324384
[TBL] [Abstract][Full Text] [Related]
12. The utility of preoperative serum thyroid-stimulating hormone level for predicting malignant nodular thyroid disease.
Jin J; Machekano R; McHenry CR
Am J Surg; 2010 Mar; 199(3):294-7; discussion 298. PubMed ID: 20226898
[TBL] [Abstract][Full Text] [Related]
13. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.
Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T
Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799
[TBL] [Abstract][Full Text] [Related]
14. Nodule heterogeneity as shown by size differences between the targeted nodule and the tumor in thyroidectomy specimen: a cause for a false-negative diagnosis of papillary thyroid carcinoma on fine-needle aspiration.
Siddiqui MA; Griffith KA; Michael CW; Pu RT
Cancer; 2008 Feb; 114(1):27-33. PubMed ID: 18085634
[TBL] [Abstract][Full Text] [Related]
15. [Association between the serum TSH concentration and thyroid cancer incidence].
Li JZ; Jin YJ; Liu X; Zhang LY
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):921-4. PubMed ID: 22340102
[TBL] [Abstract][Full Text] [Related]
16. High Urinary Iodine, Thyroid Autoantibodies, and Thyroid-Stimulating Hormone for Papillary Thyroid Cancer Risk.
Zhao H; Li H; Huang T
Biol Trace Elem Res; 2018 Aug; 184(2):317-324. PubMed ID: 29164514
[TBL] [Abstract][Full Text] [Related]
17. Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer.
Tam AA; Ozdemir D; Aydın C; Bestepe N; Ulusoy S; Sungu N; Ersoy R; Cakir B
Endocrine; 2018 Mar; 59(3):565-572. PubMed ID: 29374347
[TBL] [Abstract][Full Text] [Related]
18. Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma.
Gao Y; Qu N; Zhang L; Chen JY; Ji QH
Tumour Biol; 2016 Jun; 37(6):7453-9. PubMed ID: 26678888
[TBL] [Abstract][Full Text] [Related]
19. 'Incidental' and 'non-incidental' thyroid papillary microcarcinomas are two different entities.
Provenzale MA; Fiore E; Ugolini C; Torregrossa L; Morganti R; Molinaro E; Miccoli P; Basolo F; Vitti P
Eur J Endocrinol; 2016 Jun; 174(6):813-20. PubMed ID: 27032694
[TBL] [Abstract][Full Text] [Related]
20. Serum thyrotropin as a risk factor for thyroid malignancy in euthyroid subjects with thyroid micronodule.
Moon SS; Lee YS; Lee IK; Kim JG
Head Neck; 2012 Jul; 34(7):949-52. PubMed ID: 22127951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]